- Therapeutic Goods Administration (TGA). “Over-the-Counter Access to Low Dose Cannabidiol.” Therapeutic Goods Administration (TGA), Therapeutic Goods Administration (TGA), 21 June 2022, https://www.tga.gov.au/news/media-releases/over-counter-access-low-dose-cannabidiol.
Pamplona, F.A., da Silva, L.R., and Coan, A.C. (2018). Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis. Epilepsy Currents, 18(5), 275-278. https://pubmed.ncbi.nlm.nih.gov/30258398/
Huestis, M.A. (2007). Human Cannabinoid Pharmacokinetics. Current Drug Safety, 2(3), 238-249. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/
Therapeutic Goods Administration (TGA). “Importation, Manufacture and Supply of Unapproved Medicinal Cannabis Products.” Therapeutic Goods Administration (TGA), Therapeutic Goods Administration (TGA), 22 Nov. 2022, https://www.tga.gov.au/resources/resource/guidance/importation-manufacture-and-supply-unapproved-medicinal-cannabis-products.
- Trtchounian, A., Talbot, P. (2011). Electronic nicotine delivery systems: is there a need for regulation? Regulatory Toxicology and Pharmacology, 59(1), 74-78. https://pubmed.ncbi.nlm.nih.gov/21139013/
- Moltke, Julie, and Chandni Hindocha. “Reasons for Cannabidiol Use: A Cross-Sectional Study of CBD Users, Focusing on Self-Perceived Stress, Anxiety, and Sleep Problems.” Journal of Cannabis Research, U.S. National Library of Medicine, 18 Feb. 2021, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893882/.
The Endocannabinoid System and the Brain – Researchgate. https://www.researchgate.net/profile/Raphael-Mechoulam
R;, Mechoulam R;Parker LA;Gallily. “Cannabidiol: An Overview of Some Pharmacological Aspects.” Journal of Clinical Pharmacology, U.S. National Library of Medicine, https://pubmed.ncbi.nlm.nih.gov/12412831/.
Shannon, Scott, and Janet Opila-Lehman. “Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report.” The Permanente Journal, U.S. National Library of Medicine, 2016, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101100/.
Bergamaschi, Mateus M, et al. “Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients.” Nature News, Nature Publishing Group, 9 Feb. 2011, https://www.nature.com/articles/npp20116.
Jadoon, Khalid A, et al. “A Single Dose of Cannabidiol Reduces Blood Pressure in Healthy Volunteers in a Randomized Crossover Study.” JCI Insight, U.S. National Library of Medicine, 15 June 2017, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470879/.
Love, Charlotte A. “Cannabinoid Vaping Products Present Novel Challenges for Assessment of Respiratory Health Effects.” Academic.oup.com, https://academic.oup.com/toxsci/article/188/1/1/6618987.
Varlet, V. “Drug Vaping: From the Dangers of Misuse to New Therapeutic Devices.” MDPI, Multidisciplinary Digital Publishing Institute, 16 Dec. 2016, https://www.mdpi.com/2305-6304/4/4/29.
- Farsalinos, K. E., Romagna, G., Allifranchini, E., Ripamonti, E., Bocchietto, E., Todeschi, S., & Tsiapras, D. (2013). Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Tobacco Control, 23(Suppl 2), ii21-ii26. https://pubmed.ncbi.nlm.nih.gov/21139013/